Assessing the perceived effect of non-pharmaceutical interventions on SARS-Cov-2 transmission risk: an experimental study in Europe.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

COVID-19*/epidemiology ; COVID-19*/prevention & control ; Health Communication*; Humans ; SARS-CoV-2 ; Europe/epidemiology ; Italy

We conduct a large (N = 6567) online experiment to measure the features of non-pharmaceutical interventions (NPIs) that citizens of six European countries perceive to lower the risk of transmission of SARS-Cov-2 the most. We collected data in Bulgaria (n = 1069), France (n = 1108), Poland (n = 1104), Italy (n = 1087), Spain (n = 1102) and Sweden (n = 1097). Based on the features of the most widely adopted public health guidelines to reduce SARS-Cov-2 transmission (mask wearing vs not, outdoor vs indoor contact, short vs 90 min meetings, few vs many people present, and physical distancing of 1 or 2 m), we conducted a discrete choice experiment (DCE) to estimate the public's perceived risk of SARS-CoV-2 transmission in scenarios that presented mutually exclusive constellations of these features. Our findings indicate that participants' perception of transmission risk was most influenced by the NPI attributes of mask-wearing and outdoor meetings and the least by NPI attributes that focus on physical distancing, meeting duration, and meeting size. Differentiating by country, gender, age, cognitive style (reflective or intuitive), and perceived freight of COVID-19 moreover allowed us to identify important differences between subgroups. Our findings highlight the importance of improving health policy communication and citizens' health literacy about the design of NPIs and the transmission risk of SARS-Cov-2 and potentially future viruses.
(© 2024. The Author(s).)

Int J Environ Res Public Health. 2022 Apr 12;19(8):. (PMID: 35457521)
Front Psychol. 2015 Oct 29;6:1672. (PMID: 26579051)
Sci Rep. 2022 Jul 29;12(1):13039. (PMID: 35906452)
BMJ. 2021 Dec 1;375:n2314. (PMID: 34853011)
PLoS One. 2023 Jul 10;18(7):e0283412. (PMID: 37428731)
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4023-4028. (PMID: 28351976)
Euro Surveill. 2019 Jun;24(25):. (PMID: 31241041)
MMWR Morb Mortal Wkly Rep. 2021 Jul 27;70(30):1044-1047. (PMID: 34324480)
PLoS One. 2021 Nov 23;16(11):e0260371. (PMID: 34813628)
Vaccine. 2022 Apr 14;40(17):2506-2513. (PMID: 33958223)
JAMA Netw Open. 2023 May 1;6(5):e2310650. (PMID: 37133863)
BMJ Open. 2022 Jan 25;12(1):e056288. (PMID: 35078850)
Vaccines (Basel). 2022 Jun 30;10(7):. (PMID: 35891214)
Health Educ Q. 1984 Spring;11(1):1-47. (PMID: 6392204)
Lancet Public Health. 2021 Apr;6(4):e210-e221. (PMID: 33556325)
Risk Anal. 2004 Apr;24(2):311-22. (PMID: 15078302)
Am J Psychiatry. 2007 Jan;164(1):66-72. (PMID: 17202546)
Front Psychol. 2021 Apr 01;12:643653. (PMID: 33868115)
JAMA Netw Open. 2022 Apr 1;5(4):e228794. (PMID: 35467737)
Build Environ. 2021 Apr 15;193:107659. (PMID: 33568882)
J Psychol. 1975 Sep;91(1):93-114. (PMID: 28136248)
Int J Ment Health Addict. 2021;19(5):1875-1888. (PMID: 32346359)
Antimicrob Resist Infect Control. 2022 Jan 9;11(1):3. (PMID: 35000583)
Front Psychol. 2021 Apr 30;12:664554. (PMID: 33995222)
CMAJ Open. 2016 Aug 19;4(3):E455-E462. (PMID: 27975047)
EClinicalMedicine. 2021 Oct;40:101109. (PMID: 34522870)
Front Hum Neurosci. 2014 Jan 28;8:8. (PMID: 24478674)
Hum Vaccin Immunother. 2022 Nov 30;18(5):2068883. (PMID: 35507895)
Nat Commun. 2021 Jun 18;12(1):3737. (PMID: 34145289)
Soc Sci Med. 2022 May;301:114949. (PMID: 35381434)
Sci Adv. 2022 Feb 25;8(8):eabk0428. (PMID: 35213225)
J Infect. 2021 Sep;83(3):281-293. (PMID: 34161818)
Sci Adv. 2022 Apr 29;8(17):eabm9825. (PMID: 35476432)
BMJ. 2021 Aug 9;374:n1960. (PMID: 34373255)

101016233 HORIZON EUROPE Framework Programme

Keywords: COVID-19; DCE; NPI; Risk behaviour

Date Created: 20240228 Date Completed: 20240301 Latest Revision: 20240302

20240302

PMC10902314

10.1038/s41598-024-55447-1

38418636